49 Einträge gefunden

1. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
2. Relapse assessment following allogeneic SCT in patients with MDS and AML

   1. Christopeit, Maximilian
   2. Kröger, Nicolaus
   3. Haferlach, Torsten
   4. Bacher, Ulrike

   2014 - Forschungsinformationssystem des UKE
3. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
4. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Alpermann, Tamara
   5. Dicker, Frank
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
5. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

   1. Bacher, Ulrike
   2. Weissmann, Sandra
   3. Kohlmann, Alexander
   4. Schindela, Sonja
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Kern, Wolfgang

   2012 - Forschungsinformationssystem des UKE
6. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Grossmann, Vera
   7. Kohlmann, Alexander

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
7. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Haferlach, Torsten
   4. Wendland, Nicole
   5. Ulke, Madlen
   6. Dicker, Frank
   7. Grossmann, Vera

   2012 - Forschungsinformationssystem des UKE
8. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Macijewski, Katja
   4. Grossmann, Vera
   5. Kohlmann, Alexander
   6. Alpermann, Tamara
   7. Kowarsch, Andreas

   2012 - Forschungsinformationssystem des UKE
9. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

   1. Haferlach, Torsten
   2. Bacher, Ulrike
   3. Alpermann, Tamara
   4. Haferlach, Claudia
   5. Kern, Wolfgang
   6. Schnittger, Susanne

   2012 - Forschungsinformationssystem des UKE
10. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

    1. Bacher, Ulrike
    2. Kern, Wolfgang
    3. Alpermann, Tamara
    4. Schnittger, Susanne
    5. Haferlach, Claudia
    6. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
11. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Dicker, Frank
    5. Alpermann, Tamara
    6. Schnittger, Susanne
    7. Haferlach, Torsten

    2012 - Forschungsinformationssystem des UKE
12. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.

    1. Oyekunle, Anthony
    2. Haferlach, Torsten
    3. Kröger, Nicolaus
    4. Klyuchnikov, Evgeny
    5. Zander, Axel R.
    6. Schnittger, Susanne
    7. Bacher, Ulrike

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
13. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Kern, Wolfgang
    5. Alpermann, Tamara
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
14. Unusual course of myelodysplastic syndrome with presumed familial origin.

    1. Bacher, Ulrike
    2. Ocheni, Sunday
    3. Schafhausen, Philippe
    4. Oyekunle, Anthony
    5. Dierlamm, Judith
    6. Zander, Axel R.
    7. Bokemeyer, Carsten

    2011 - Forschungsinformationssystem des UKE
15. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Schnittger, Susanne
    5. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE
16. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Schnittger, Susanne
    4. Kreipe, Hans
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE
17. Ganglioneuroblastoma infiltrating the bone marrow in an adult.

    1. Bacher, Ulrike
    2. Christopeit, Maximilian
    3. Wiedemann, Bettina
    4. Leuschner, Ivo
    5. Haferlach, Torsten
    6. Choschzick, Matthias

    2011 - Forschungsinformationssystem des UKE
18. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Fehse, Boris
    4. Schnittger, Susanne
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
19. A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Eder, Christiane
    4. Lohse, Peter
    5. Haferlach, Claudia
    6. Kern, Wolfgang
    7. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE
20. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

    1. Haferlach, Claudia
    2. Bacher, Ulrike
    3. Kohlmann, Alexander
    4. Schindela, Sonja
    5. Alpermann, Tamara
    6. Kern, Wolfgang
    7. Schnittger, Susanne

    2011 - Forschungsinformationssystem des UKE - frei zugänglich